Clinical impact of blood storage lesions

American Journal of Hematology

Volumn 85, Issue 2, 2010, Pages 117-122

  Zubair, Abba C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ADENOSINE TRIPHOSPHATE; FRESH FROZEN PLASMA;

ACIDITY; BACTERIUM CONTAMINATION; BLOOD BANK; BLOOD STORAGE; BLOOD TRANSFUSION; CRYOPRECIPITATION; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ERYTHROCYTE TRANSFUSION; HUMAN; IRRADIATION; LEUKAPHERESIS; MORBIDITY; MORPHOLOGY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROCESSING; REVIEW; SEPSIS; STORAGE TEMPERATURE; THROMBOCYTE; TRANSFUSION RELATED ACUTE LUNG INJURY; VASCULARIZATION;

BLOOD BANKS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; PRESERVATION, BIOLOGICAL;

EID: 75449109181     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21599     Document Type: Review

References (75)

1. Rous P, Turner JR. The preservation of living red cells in vitro. I. Methods of preservation. J Exp Med 1916;23:219-237.
2. Greenwalt TJ, Desforges J, Farhi LE, Hubbard JB, Laird NM, Longnecker DE, Morrison JC, Mosley JW, Oparil S, Saletta JD, Swisher SN, Vyas GN. Consensus conference Perioperative red blood cell transfusion. JAMA 1988;260: 2700-2703.
3. Hamasaki N, Yamamoto M. Red blood cell function and blood storage. Vox Sang 2000;79:191-197.
4. Tinmouth A, Chin-Yee I. The clinical consequences of the red cell storage lesion. Transfusion Med Rev 2001;15:91-107.
5. Hogman CF. Preparation and preservation of red cells. Vox Sang 1998;74 (Suppl 2):177-187.
6. Spiess BD, Gillies BS, Chandler W, Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothoracic Vascular Anesthesia 1995;9:168-173.
7. Holme S, Elfath MD, Whitley P. Evaluation of in vivo and in vitro quality of apheresis-collected RBC stored for 42 days. Vox Sang 1998;75:212-217.
8. Beutler E, Wood L. The in vivo regeneration of red cell 2,3 diphosphoglyceric acid (DPG) after transfusion of stored blood. J Lab Clin Med 1969;74:300-304.
9. Simon ER. Adenine in blood banking. Transfusion 1977;17:317-325.
10. Greenwalt TJ, Bryan DJ, Dumaswala UJ. Erythrocyte membrane vesiculation and changes in membrane composition during storage in citrate-phosphatedextrose- adenine-1. Vox Sang 1984;47:261-270.
11. Kriebardis AG, Antonelou MH, Stamoulis KE, et al. Storage-dependent remodeling of the red blood cell membrane is associated with increased immunoglobulin G binding, lipid raft rearrangement, and caspase activation. Transfusion 2007;47:1212-1220.
12. Kriebardis AG, Antonelou MH, Stamoulis KE, et al. Progressive oxidation of cytoskeletal proteins and accumulation of denatured hemoglobin in stored red cells. J Cell Mol Med 2007;11:148-155.
13. Kriebardis AG, Antonelou MH, Stamoulis KE, et al. RBC-derived vesicles during storage: Ultrastructure, protein composition, oxidation, and signaling components. Transfusion 2008;48:1943-1953.
14. Bosman GJ, Klaarenbeek JM, Luten M, Bos HJ. Storage-related changes in erythrocyte band 3: Not a case for the Diego blood group antigens. Cell Mol Biol (Noisy-le-Gr, France) 2005;51:195-200.
15. Luten M, Roerdinkholder-Stoelwinder B, Schaap NP, et al. Survival of red blood cells after transfusion: A comparison between red cells concentrates of different storage periods. Transfusion 2008;48:1478-1485.
16. Salzer U, Zhu R, Luten M, et al. Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion 2008;48:451-462.
17. Willekens FL, Roerdinkholder-Stoelwinder B, Groenen-Dopp YA, et al. Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood 2003;101:747-751.
18. Bosman GJ, Werre JM, Willekens FL, Novotny VM. Erythrocyte ageing in vivo and in vitro: Structural aspects and implications for transfusion. Transfusion Med (Oxford, England) 2008;18:335-347.
19. Bosman GJ, Willekens FL, Werre JM. Erythrocyte aging: A more than superficial resemblance to apoptosis? Cell Physiol Biochem 2005;16:1-8.
20. Willekens FL, Werre JM, Groenen-Dopp YA, et al. Erythrocyte vesiculation: A self-protective mechanism? Br J Haematol 2008;141:549-556.
21. Card RT. Red cell membrane changes during storage. Transfusion Med Rev 1988;2:40-47.
22. Card RT, Lemire GG, Bharadwaj B. Alterations in red cell metabolism during and following cardiac bypass surgery. Can J Surgery 1978;21:151-154.
23. Silva M, editor. Standards for Blood Banks and Transfusion Services. Bethesda, MD: AABB; 2004.119.
24. Latham JT, Jr, Bove JR, Weirich FL. Chemical and hematologic changes in stored CPDA-1 blood. Transfusion 1982;22:158-159.
25. Simon GE, Bove JR. The potassium load from blood transfusion. Postgraduate Med 1971;49:61-64.
26. Cambell-Lee SA NP. Packed RBCs and related products. In: Hillyer CD SL,Ness PM,Anderson KC, editors. Blood Banking and Transfusion Medicine Basic Principles and Practice. Philadelphia: Churchill Livingstone; 2003. pp 145-152.
27. Davenport RD, Kunkel SL. Cytokine roles in hemolytic and nonhemolytic transfusion reactions. Transfusion Med Rev 1994;8:157-168.
28. Payne R. Leukocyte agglutinins in human sera; correlation between blood transfusions and their development. AMA 1957;99:587-606.
29. J. McFarland, Kagen L, Braine H, Kickler T, Ness P, Fuller A, Slichter S, Gernsheimer T, Townsend-McCal D, Kao K.-J., Noyes W, Weiner R, Hudson S, Waldman-Slone A, Schiffer C, Lee E, Norris D, McCullough J, Enright H, Lennon S, Clay M, Woodson R, Meisch M, Noordsij P, Davis K, Mickel M, Gillespie MJ, Ng G, Parker S, Corley S, Rodey G, Sell K, Nemo G, Follmann D, Hernandez M, Hollingsworth C, Klein H, Dutcher J, Frantantoni J, Kruskall M, Macklin R, Strauss R, Wittes J. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997;337:1861-1869.
30. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973;5:253-259.
31. Sengar DP, Opelz G, Terasaki PI. Outcome of kidney transplants and suppression of mixed leukocyte culture by plasma. Transplant Proc 1973;5:641-647.
32. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of .ltered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-3603.
33. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993;269:3024-3029.
34. Walsh TS, McArdle F, McLellan SA, et al. Does the storage time of transfused red blood cells in.uence regional or global indexes of tissue oxygenation in anemic critically ill patients? Crit Care Med 2004;32:364-371.
35. Leitman SF, Holland PV. Irradiation of blood products. Indications and guidelines. Transfusion 1985;25:293-303.
36. Moroff G, Leitman SF, Luban NL. Principles of blood irradiation, dose validation, and quality control. Transfusion 1997;37:1084-1092.
37. Davey RJ, McCoy NC, Yu M, et al. The effect of prestorage irradiation on posttransfusion red cell survival. Transfusion 1992;32:525-528.
38. Moroff G, Holme S, AuBuchon JP, et al. Viability and in vitro properties of AS-1 red cells after gamma irradiation. Transfusion 1999;39:128-134.
39. Manno CS, Hedberg KW, Kim HC, et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991;77:930-936.
40. Mou SS, Giroir BP, Molitor-Kirsch EA, et al. Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants. N Engl J Med 2004;351:1635-1644.
41. Leal-Noval SR, Rincon-Ferrari MD, Garcia-Curiel A, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001;119:1461-1468.
42. Vamvakas EC, Carven JH. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: Effect of the length of storage of transfused red cells. Transfusion 1999;39:701-710.
43. Basran S, Frumento RJ, Cohen A, et al. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesthesia Analgesia 2006;103:15-20.
44. Zallen G, Offner PJ, Moore EE, et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg 1999;178:570-572.
45. Keller ME, Jean R, LaMorte WW, et al. Effects of age of transfused blood on length of stay in trauma patients: A preliminary report. J Trauma 2002;53: 1023-1025.
46. Yap CH, Lau L, Krishnaswamy M, et al. Age of transfused red cells and early outcomes after cardiac surgery. Ann Thorac Surg 2008;86:554-559.
47. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008;358:1229-1239.
48. Mynster T, Nielsen HJ. Storage time of transfused blood and disease recurrence after colorectal cancer surgery. Dis Colon Rectum 2001;44:955-964.
49. Offner PJ, Moore EE, Bif. WL, et al. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg 2002;137:711-716; discussion 716-717.
50. Vamvakas EC, Carven JH. Length of storage of transfused red cells and post-operative morbidity in patients undergoing coronary artery bypass graft surgery. Transfusion 2000;40:101-109.
51. Leal-Noval SR, Jara-Lopez I, Garcia-Garmendia JL, et al. In.uence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 2003;98:815-822.
52. Purdy FR, Tweeddale MG, Merrick PM. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 1997;44:1256-1261.
53. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: Epidemiology and a prospective analysis of etiologic factors. Blood 2003;101:454-462.
54. Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: A retrospective study. Transfusion 1997;37:719-726.
55. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007;136:788-799.
56. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005;105:2266-2273.
57. Gajic O, Rana R, Mendez JL, et al. Acute lung injury after blood transfusion in mechanically ventilated patients. Transfusion 2004;44:1468-1474.
58. Gajic O, Rana R, Winters JL, et al. Transfusion-related acute lung injury in the critically ill: Prospective nested case-control study. Am J Respir Crit Care Med 2007;176:886-891.
59. Toy P, Gajic O. Transfusion-related acute lung injury. Anesthesia Analgesia 2004;99:1623-1624.
60. Khan SY, Kelher MR, Heal JM, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006;108:2455-2462.
61. Silliman CC, Bjornsen AJ, Wyman TH, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003;43: 633-640.
62. Williamson LM, Lowe S, Love EM, et al. Serious hazards of transfusion (SHOT) initiative: Analysis of the .rst two annual reports. BMJ (Clin Res Ed) 1999;319:16-19.
63. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001;41:1493-1499.
64. Jacobs MR, Good CE, Lazarus HM, Yomtovian RA. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis 2008;46: 1214-1220.
65. Jacobs MR, Palavecino E, Yomtovian R. Don't bug me: The problem of bacterial contamination of blood components - Challenges and solutions. Transfusion 2001;41:1331-1334.
66. Kleinman SH, Kamel HT, Harpool DR, et al. Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets. Transfusion 2006;46: 1787-1794.
67. Yomtovian R, Lazarus HM, Goodnough LT, et al. A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 1993;33:902-909.
68. Eder AF, Kennedy JM, Dy BA, et al. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: The American Red Cross experience (2004-2006). Transfusion 2007;47:1134-1142.
69. Fang CT, Chambers LA, Kennedy J, et al. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion 2005;45:1845-1852.
70. Whitaker BI, Sullivan M. The 2005 Nationwide Blood Collection and Utilization Survey Report.Washington DC: Department of Health and Human Services; 2006.
71. Hebert PC, Wells G, Blajchman MA, et al.; Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators. N Engl J Med 1999;340:409-417.
72. Foss NB, Kristensen MT, Palm H, Kehlet H. Postoperative pain after hip fracture is procedure speci.c. Br J Anaesthesia 2009;102:111-116.
73. Feagan BG, Wong CJ, Kirkley A, et al. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med 2000;133:845-854.
74. Goldberg MA. Erythropoiesis, erythropoietin, and iron metabolism in elective surgery: Preoperative strategies for avoiding allogeneic blood exposure. Am J Surg 1995;170:37S-43S.
75. Niranjan G, Asimakopoulos G, Karagounis A, et al. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on-versus off-cardiopulmonary bypass: A randomized trial. Eur J Cardiothorac Surg 2006;30:271-277.